• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

    Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

    Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

    Impressions : 1583

    Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

    Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

    April kicked off with Danish drugmaker Genmab buying ProfoundBio for US$ 1.8 billion in cash. ProfoundBio is a clinical stage b...

    Impressions : 1139

    EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer

    This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...

    Impressions : 3985

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.